NOVARTIS AG (NVSEF)
Clinical trial NCT03945318 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-06-10 3. primary completion date: 2026-04-30 → 2026-06-10
Clinical trial NCT03945318 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-06-10 3. primary completion date: 2026-04-30 → 2026-06-10
Form 6-K- SaverOne Signs Pilot Agreement with RBtec to Expand its RF Sensing Technology into the Security Market
Clinical trial NCT05208047: status: ACTIVE_NOT_RECRUITING → RECRUITING.
Clinical trial NCT06785675 updates: 1. completion date: 2026-09-30 → 2026-10-10 2. primary completion date: 2026-09-30 → 2026-10-10 3. enrollment: 48 → 53 participants
Clinical trial NCT07592572 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-05-20
Clinical trial NCT07110610 updates: 1. completion date: 2026-07-01 → 2026-09-01 2. primary completion date: 2026-07-01 → 2026-09-01
TAO Synergies Set to Join the Russell Microcap® Index as a Leading Public Gateway to Decentralized AI
Virtuix Expands Defense Presence at TSIS 2026 Following U.S. Air Force Award and Marine Corps Collaboration
VIA Deadline Alert: The Gross Law Firm Reminds Via Transportation, Inc. (VIA) Investors of Securities Class Action Deadline on August 10, 2026
Jackson Grants More Than $675,000 to Support Nonprofits Serving Lansing, Nashville and Chicago